These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33418492)

  • 1. Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease.
    Chung SJ; Rim JH; Ji D; Lee S; Yoo HS; Jung JH; Baik K; Choi Y; Ye BS; Sohn YH; Yun M; Lee SG; Lee PH
    Nutrition; 2021 Mar; 83():111090. PubMed ID: 33418492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
    Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
    Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
    J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
    Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
    Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma trimethylamine N-oxide, a gut microbe-generated phosphatidylcholine metabolite, is associated with autism spectrum disorders.
    Quan L; Yi J; Zhao Y; Zhang F; Shi XT; Feng Z; Miller HL
    Neurotoxicology; 2020 Jan; 76():93-98. PubMed ID: 31704102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing trimethylamine N-oxide levels as a predictor of early neurological deterioration in patients with acute ischemic stroke.
    Hou L; Zhang Y; Zheng D; Shi H; Zou C; Zhang H; Lu Z; Du H
    Neurol Res; 2020 Feb; 42(2):153-158. PubMed ID: 31928326
    [No Abstract]   [Full Text] [Related]  

  • 8. A water-soluble tomato extract rich in secondary plant metabolites lowers trimethylamine-n-oxide and modulates gut microbiota: a randomized, double-blind, placebo-controlled cross-over study in overweight and obese adults.
    Rehman A; Tyree SM; Fehlbaum S; DunnGalvin G; Panagos CG; Guy B; Patel S; Dinan TG; Duttaroy AK; Duss R; Steinert RE
    J Nutr; 2023 Jan; 153(1):96-105. PubMed ID: 36913483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Choline Forms and Gut Microbiota Composition on Trimethylamine-
    Cho CE; Aardema NDJ; Bunnell ML; Larson DP; Aguilar SS; Bergeson JR; Malysheva OV; Caudill MA; Lefevre M
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High plasma levels of trimethylamine N-oxide are associated with poor outcome in intracerebral hemorrhage patients.
    Zhai Q; Sun T; Sun C; Yan L; Wang X; Wang Y; Sun J; Zhao Y
    Neurol Sci; 2021 Mar; 42(3):1009-1016. PubMed ID: 32705490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.
    Senthong V; Wang Z; Li XS; Fan Y; Wu Y; Tang WH; Hazen SL
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27287696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency.
    Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF
    Front Immunol; 2020; 11():574500. PubMed ID: 33042155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A red wine intervention does not modify plasma trimethylamine N-oxide but is associated with broad shifts in the plasma metabolome and gut microbiota composition.
    Haas EA; Saad MJA; Santos A; Vitulo N; Lemos WJF; Martins AMA; Picossi CRC; Favarato D; Gaspar RS; Magro DO; Libby P; Laurindo FRM; Da Luz PL;
    Am J Clin Nutr; 2022 Dec; 116(6):1515-1529. PubMed ID: 36205549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
    Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
    Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of dynamic monitoring plasma TMAO level in pulmonary arterial hypertension - a cohort study.
    Yang Y; Li X; Wang P; Shu S; Liu B; Liang Y; Yang B; Zhao Z; Luo Q; Liu Z; Zheng L; Zeng Q; Xiong C
    Ther Adv Respir Dis; 2024; 18():17534666231224692. PubMed ID: 38205629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Changes in Gut Microbial Metabolite Trimethylamine N-Oxide and Coronary Heart Disease Risk.
    Heianza Y; Ma W; DiDonato JA; Sun Q; Rimm EB; Hu FB; Rexrode KM; Manson JE; Qi L
    J Am Coll Cardiol; 2020 Feb; 75(7):763-772. PubMed ID: 32081286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status.
    Voigt RM; Wang Z; Brown JM; Engen PA; Naqib A; Goetz CG; Hall DA; Metman LV; Shaikh M; Forsyth CB; Keshavarzian A
    Neurobiol Dis; 2022 Aug; 170():105780. PubMed ID: 35654277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial.
    Cho CE; Taesuwan S; Malysheva OV; Bender E; Tulchinsky NF; Yan J; Sutter JL; Caudill MA
    Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27377678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota-derived Trimethylamine N-oxide Predicts Cardiovascular Risk After STEMI.
    Matsuzawa Y; Nakahashi H; Konishi M; Sato R; Kawashima C; Kikuchi S; Akiyama E; Iwahashi N; Maejima N; Okada K; Ebina T; Hibi K; Kosuge M; Ishigami T; Tamura K; Kimura K
    Sci Rep; 2019 Aug; 9(1):11647. PubMed ID: 31406181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multi-omic Association Study of Trimethylamine N-Oxide.
    Manor O; Zubair N; Conomos MP; Xu X; Rohwer JE; Krafft CE; Lovejoy JC; Magis AT
    Cell Rep; 2018 Jul; 24(4):935-946. PubMed ID: 30044989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.